Skip to content

PATHOLOGIE: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PATHOLOGIE

BE 0461.220.647
NACE 86.220, Specialist medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-
not filed
Equity
€4,324
2024 · €24,233-€19,909
Cash
€142,307
2024 · €118,828+€23,479
Balance sheet total
€988,601
2024 · €1.2m-€182,269

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€205,748

    down €205,748 (-19.6%), from €1.1m to €846,293

    of which Other amounts receivable: -€203,121

  • Cash +€23,479

    up €23,479 (+19.8%), from €118,828 to €142,307

Equity and liabilities
  • Other debts -€172,473

    down €172,473 (-15.2%), from €1.1m to €965,837

  • Contributions -€18,090

    down €18,090 (-80.7%), from €22,415 to €4,324

Income statement
  • Taxes -€1,123

    down €1,123, from €588 to -€534

  • Gross operating margin -€1,088

    down €1,088 (-59.0%), from €1,845 to €757

  • Other operating charges +€33

    up €33 (+2.7%), from €1,214 to €1,246

From the 2024 result to the 2025 result

effect on the result

The net result is not in both sets of accounts; without it the difference cannot be explained line by line.

Cash bridge derived

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.

Every line side by side 29 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,170,870 €988,601 -€182,269 -15.6%
Current assets 29/58 €1,170,870 €988,601 -€182,269 -15.6%
Amounts receivable within one year 40/41 €1,052,042 €846,293 -€205,748 -19.6%
Trade receivables 40 €2,628 €0 -€2,628 -100.0%
Other amounts receivable 41 €1,049,414 €846,293 -€203,121 -19.4%
Cash at bank and in hand 54/58 €118,828 €142,307 +€23,479 +19.8%
Deferred charges and accrued income 490/1 €0 - =
Total equity and liabilities 10/49 €1,170,870 €988,601 -€182,269 -15.6%
Equity 10/15 €24,233 €4,324 -€19,909 -82.2%
Contributions 10/11 €22,415 €4,324 -€18,090 -80.7%
Reserves 13 €1,819 €0 -€1,819 -100.0%
Non-distributable reserves 130/1 €1,416 €0 -€1,416 -100.0%
Reserves not available under the articles 1311 €1,416 €0 -€1,416 -100.0%
Distributable reserves 133 €403 €0 -€403 -100.0%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €1,146,636 €984,276 -€162,360 -14.2%
Amounts payable within one year 42/48 €1,146,636 €984,276 -€162,360 -14.2%
Trade debts 44 €8,326 €18,439 +€10,113 +121.5%
Suppliers 440/4 €8,326 €18,439 +€10,113 +121.5%
Other amounts payable 47/48 €1,138,311 €965,837 -€172,473 -15.2%
Other operating charges 640/8 €1,214 €1,246 +€33 +2.7%
Gross operating margin 9900 €1,845 €757 -€1,088 -59.0%
Operating profit (loss) 9901 €632 -€489 -€1,121
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €43 €45 +€2 +3.5%
Recurring financial charges 65 €43 €45 +€2 +3.5%
Profit (loss) for the period before taxes 9903 €588 -€534 -€1,123
Income taxes 67/77 €588 -€534 -€1,123

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.